NORWEGIAN PHARMA AS

NORWEGIAN PHARMA AS is registered as a limited company in Gjesdal, Rogaland with organisation number 893844422. The business is classified under wholesale of other food (NACE 46.380). The company was incorporated in 2009. Registered share capital is NOK 100,000, divided into 100 shares. The company's stated purpose is: “Drive handel med naturprodukter, herunder eksport av samme, samt hva hermed står i naturlig forbindelse. Selskapet kan også opptre som interessent i andre foretagender, ved aksjetegning eller på annen måte.”. The most recent filed accounts, for the 2025 financial year, show NOK 8.5m in revenue and NOK 1.3m in operating profit.

Key figures · 2025

Revenue

NOK 8.5m

Operating profit

NOK 1.3m

Equity

NOK 2.9m

Est. value

NOK 6.1m

Financial health · 2025

Liquidity

3.68

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

72.5%

Very good

Equity as a share of total capital

Who owns NORWEGIAN PHARMA AS?

HAVEN FINANS AS

20.0%

NORWEGIAN PHARMA AS

NOK 8.5m rev. · NOK 1.3m profit

NORWEGIAN PHARMA AS has 5 registered shareholders:

• HAVEN FINANS AS 20.0%
• ALVIRO AS 20.0%
• FATTER & GUTTA AS 20.0%
• ARVE HØGEMARK 20.0%
• FREDRIK HAVEN 20.0%

All shareholders and roles →

Frequently asked questions about NORWEGIAN PHARMA AS

Who owns NORWEGIAN PHARMA AS?

HAVEN FINANS AS is the largest registered owner, with 20.0%.

What is the revenue of NORWEGIAN PHARMA AS?

NORWEGIAN PHARMA AS had revenue of NOK 8.5m in 2025.

Who is the general manager of NORWEGIAN PHARMA AS?

Arve Leroux Høgemark is registered as general manager of NORWEGIAN PHARMA AS.

Where is NORWEGIAN PHARMA AS based?

NORWEGIAN PHARMA AS has its business address in Ålgård.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.